Phase I trial of alofanib (RPT835) in combination with paclitaxel and carboplatin for the treatment of platinum-resistant ovarian cancer
Latest Information Update: 30 Jul 2015
At a glance
- Drugs Alofanib (Primary) ; Carboplatin; Paclitaxel
- Indications Ovarian cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 30 Jul 2015 New trial record